Form 4: Cirrus Logic VP of R&D Executes Stock Option and Sells Shares Under 10b5-1 Plan

Cirrus Logic's VP of R&D, Jeffrey W. Baumgartner, exercised stock options and sold shares under a pre-arranged 10b5-1 trading plan.

Summary

• Jeffrey W. Baumgartner, VP of R&D at Cirrus Logic, executed a stock option to acquire 5,542 shares of common stock at $68.56 per share.
• Simultaneously, Mr. Baumgartner sold 5,542 shares of common stock at a weighted average price of $101.05 per share.
• The sales were executed under a pre-arranged Rule 10b5-1 trading plan adopted on August 20, 2024.
• Following these transactions, Mr. Baumgartner directly owns 10,381 shares of Cirrus Logic common stock.
• The stock option was fully vested on November 6, 2023.

Sentiment

Score: 5

Explanation: The document reflects a routine transaction under a pre-arranged plan, with no significant positive or negative implications.

Positives

• The execution of the stock option and subsequent sale of shares indicates that the executive is taking advantage of the company's stock performance.
• The use of a 10b5-1 plan suggests a structured and transparent approach to trading.

Negatives

• The sale of shares by a high-ranking executive could be interpreted negatively by some investors, although it is part of a pre-arranged plan.

Risks

• Executive stock sales can sometimes create short-term price volatility.
• The market may react negatively to insider selling, even if it is part of a pre-planned strategy.

Industry Context

This filing is a routine disclosure of insider trading activity, which is common in publicly traded companies. The use of a 10b5-1 plan is a standard practice to avoid accusations of insider trading.

Comparison to Industry Standards

• The use of a 10b5-1 trading plan is a common practice among executives at publicly traded companies, including those in the semiconductor industry like Texas Instruments (TXN) and Analog Devices (ADI).
• The vesting schedule of the stock options is typical for executive compensation packages.
• The sale of shares after exercising options is a standard practice for executives to realize the value of their compensation.

Stakeholder Impact

• The transaction has a minor impact on shareholders as it is a routine insider sale under a pre-arranged plan.
• The sale of shares by an executive may cause some short-term price volatility.

Key Dates

Keywords

insider trading, stock options, Rule 10b5-1, executive compensation, share sale, Cirrus Logic, CRUS